Compare MEDP & DPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | DPZ |
|---|---|---|
| Founded | 1992 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 13.5B |
| IPO Year | 2016 | 2004 |
| Metric | MEDP | DPZ |
|---|---|---|
| Price | $489.52 | $361.60 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 24 |
| Target Price | ★ $498.25 | $472.00 |
| AVG Volume (30 Days) | 258.9K | ★ 925.9K |
| Earning Date | 04-22-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 1.94% |
| EPS Growth | ★ 20.98 | 5.27 |
| EPS | 15.28 | ★ 17.57 |
| Revenue | N/A | ★ $4,939,994,000.00 |
| Revenue This Year | $13.15 | $8.14 |
| Revenue Next Year | $7.47 | $4.02 |
| P/E Ratio | $31.42 | ★ $20.47 |
| Revenue Growth | N/A | ★ 4.96 |
| 52 Week Low | $250.05 | $346.31 |
| 52 Week High | $628.92 | $499.08 |
| Indicator | MEDP | DPZ |
|---|---|---|
| Relative Strength Index (RSI) | 58.96 | 38.90 |
| Support Level | $489.09 | N/A |
| Resistance Level | $501.30 | $418.07 |
| Average True Range (ATR) | 14.70 | 9.96 |
| MACD | 5.29 | -2.20 |
| Stochastic Oscillator | 95.75 | 26.74 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Domino's is the world's largest pizza chain, surpassing $19 billion in system sales with over 21,300 stores across more than 90 markets at the end of 2024. Around 33% of its units are in the US. The business is 99% franchised. Domino's operates through three segments: supply chain (60% of revenue), US stores (33%), and international franchises (7%). The firm generates the bulk of its revenue by supplying food to stores in the US and Canada through a vertically integrated network of 25 manufacturing and supply chain facilities, which primarily produce and distribute dough, and collecting brand royalties and marketing fees from franchisees. Domino's also generates revenue from sales at company-owned stores.